APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sexual Dysfunction Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sexual Dysfunction Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025192 pages

Choose your research edition.

Industry ResearchSexual Dysfunction Drugs Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Sexual Dysfunction Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Sexual Dysfunction Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sexual Dysfunction Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sexual Dysfunction Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sexual Dysfunction Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sexual Dysfunction Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sexual Dysfunction Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sexual Dysfunction Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sexual Dysfunction Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sexual Dysfunction Drugs include Takeda, Teva Pharmaceutical Industries, Merck, Eli Lilly, Pfizer, GlaxoSmithKline, Bayer, AbbVie and Vietstar Biomedical Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sexual Dysfunction Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sexual Dysfunction Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sexual Dysfunction Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sexual Dysfunction Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Sexual Dysfunction Drugs Segment by Company

Takeda

Teva Pharmaceutical Industries

Merck

Eli Lilly

Pfizer

GlaxoSmithKline

Bayer

AbbVie

Vietstar Biomedical Research

S1 Biopharma

NexMed

Leadiant Biosciences

Ivix LLX

Emotional Brain

Apricus Biosciences

Sexual Dysfunction Drugs Segment by Type

Hormonal Therapy

Transurethral Therapy

Oral Therapy

Intracavernosal Therapy

Sexual Dysfunction Drugs Segment by Application

Male

Female

Sexual Dysfunction Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sexual Dysfunction Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sexual Dysfunction Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sexual Dysfunction Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sexual Dysfunction Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sexual Dysfunction Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sexual Dysfunction Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sexual Dysfunction Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sexual Dysfunction Drugs Industry Trends Table 2. Sexual Dysfunction Drugs Industry Drivers Table 3. Sexual Dysfunction Drugs Industry Opportunities and Challenges Table 4. Sexual Dysfunction Drugs Industry Restraints Table 5. Global Sexual Dysfunction Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sexual Dysfunction Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sexual Dysfunction Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Sexual Dysfunction Drugs Sales Market Share by Manufacturers Table 9. Global Sexual Dysfunction Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Sexual Dysfunction Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sexual Dysfunction Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sexual Dysfunction Drugs Manufacturers, Product Type & Application Table 13. Global Sexual Dysfunction Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sexual Dysfunction Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Hormonal Therapy Table 17. Major Manufacturers of Transurethral Therapy Table 18. Major Manufacturers of Oral Therapy Table 19. Major Manufacturers of Intracavernosal Therapy Table 20. Global Sexual Dysfunction Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Sexual Dysfunction Drugs Sales by Type (2021-2026) & (K Units) Table 22. Global Sexual Dysfunction Drugs Sales by Type (2027-2032) & (K Units) Table 23. Global Sexual Dysfunction Drugs Sales Market Share by Type (2021-2026) Table 24. Global Sexual Dysfunction Drugs Sales Market Share by Type (2027-2032) Table 25. Global Sexual Dysfunction Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Sexual Dysfunction Drugs Revenue by Type (2021-2026) & (K Units) Table 27. Global Sexual Dysfunction Drugs Revenue by Type (2027-2032) & (K Units) Table 28. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Male Table 31. Major Manufacturers of Female Table 32. Global Sexual Dysfunction Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Sexual Dysfunction Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Sexual Dysfunction Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Sexual Dysfunction Drugs Sales Market Share by Application (2021-2026) Table 36. Global Sexual Dysfunction Drugs Sales Market Share by Application (2027-2032) Table 37. Global Sexual Dysfunction Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Sexual Dysfunction Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Sexual Dysfunction Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Sexual Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Sexual Dysfunction Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Sexual Dysfunction Drugs Sales Market Share by Region (2021-2026) Table 45. Global Sexual Dysfunction Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Sexual Dysfunction Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Sexual Dysfunction Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Sexual Dysfunction Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Sexual Dysfunction Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Sexual Dysfunction Drugs Revenue Market Share by Region (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Takeda Sexual Dysfunction Drugs Product Portfolio Table 68. Takeda Recent Development Table 69. Teva Pharmaceutical Industries Company Information Table 70. Teva Pharmaceutical Industries Business Overview Table 71. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio Table 73. Teva Pharmaceutical Industries Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Sexual Dysfunction Drugs Product Portfolio Table 78. Merck Recent Development Table 79. Eli Lilly Company Information Table 80. Eli Lilly Business Overview Table 81. Eli Lilly Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Eli Lilly Sexual Dysfunction Drugs Product Portfolio Table 83. Eli Lilly Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Sexual Dysfunction Drugs Product Portfolio Table 88. Pfizer Recent Development Table 89. GlaxoSmithKline Company Information Table 90. GlaxoSmithKline Business Overview Table 91. GlaxoSmithKline Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio Table 93. GlaxoSmithKline Recent Development Table 94. Bayer Company Information Table 95. Bayer Business Overview Table 96. Bayer Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Bayer Sexual Dysfunction Drugs Product Portfolio Table 98. Bayer Recent Development Table 99. AbbVie Company Information Table 100. AbbVie Business Overview Table 101. AbbVie Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. AbbVie Sexual Dysfunction Drugs Product Portfolio Table 103. AbbVie Recent Development Table 104. Vietstar Biomedical Research Company Information Table 105. Vietstar Biomedical Research Business Overview Table 106. Vietstar Biomedical Research Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio Table 108. Vietstar Biomedical Research Recent Development Table 109. S1 Biopharma Company Information Table 110. S1 Biopharma Business Overview Table 111. S1 Biopharma Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. S1 Biopharma Sexual Dysfunction Drugs Product Portfolio Table 113. S1 Biopharma Recent Development Table 114. NexMed Company Information Table 115. NexMed Business Overview Table 116. NexMed Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. NexMed Sexual Dysfunction Drugs Product Portfolio Table 118. NexMed Recent Development Table 119. Leadiant Biosciences Company Information Table 120. Leadiant Biosciences Business Overview Table 121. Leadiant Biosciences Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio Table 123. Leadiant Biosciences Recent Development Table 124. Ivix LLX Company Information Table 125. Ivix LLX Business Overview Table 126. Ivix LLX Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Ivix LLX Sexual Dysfunction Drugs Product Portfolio Table 128. Ivix LLX Recent Development Table 129. Emotional Brain Company Information Table 130. Emotional Brain Business Overview Table 131. Emotional Brain Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Emotional Brain Sexual Dysfunction Drugs Product Portfolio Table 133. Emotional Brain Recent Development Table 134. Apricus Biosciences Company Information Table 135. Apricus Biosciences Business Overview Table 136. Apricus Biosciences Sexual Dysfunction Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio Table 138. Apricus Biosciences Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Sexual Dysfunction Drugs Distributors List Table 142. Sexual Dysfunction Drugs Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Sexual Dysfunction Drugs Product Image Figure 2. Global Sexual Dysfunction Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sexual Dysfunction Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Sexual Dysfunction Drugs Sales (2021-2032) & (K Units) Figure 5. Global Sexual Dysfunction Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Sexual Dysfunction Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Hormonal Therapy Image Figure 9. Transurethral Therapy Image Figure 10. Oral Therapy Image Figure 11. Intracavernosal Therapy Image Figure 12. Global Sexual Dysfunction Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Sexual Dysfunction Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Sexual Dysfunction Drugs Sales Market Share by Type (2021-2032) Figure 15. Global Sexual Dysfunction Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Sexual Dysfunction Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Sexual Dysfunction Drugs Revenue Market Share by Type (2021-2032) Figure 18. Male Image Figure 19. Female Image Figure 20. Global Sexual Dysfunction Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Sexual Dysfunction Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Sexual Dysfunction Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Sexual Dysfunction Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Sexual Dysfunction Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Sexual Dysfunction Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Sexual Dysfunction Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Sexual Dysfunction Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Sexual Dysfunction Drugs Sales Market Share by Country (2021-2032) Figure 40. China Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Sexual Dysfunction Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Sexual Dysfunction Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Sexual Dysfunction Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Sexual Dysfunction Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Sexual Dysfunction Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Sexual Dysfunction Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Sexual Dysfunction Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Hormonal Therapy
  • Transurethral Therapy
  • Oral Therapy
  • Intracavernosal Therapy
Applications
  • Male
  • Female
Companies covered
  • Takeda
  • Teva Pharmaceutical Industries
  • Merck
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AbbVie
  • Vietstar Biomedical Research
  • S1 Biopharma
  • NexMed
  • Leadiant Biosciences
  • Ivix LLX
  • Emotional Brain
  • Apricus Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sexual Dysfunction Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sexual Dysfunction Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sexual Dysfunction Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sexual Dysfunction Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sexual Dysfunction Drugs Market Dynamics
  1. 2.1 Sexual Dysfunction Drugs Industry Trends
  2. 2.2 Sexual Dysfunction Drugs Industry Drivers
  3. 2.3 Sexual Dysfunction Drugs Industry Opportunities and Challenges
  4. 2.4 Sexual Dysfunction Drugs Industry Restraints
3 Sexual Dysfunction Drugs Market by Manufacturers
  1. 3.1 Global Sexual Dysfunction Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sexual Dysfunction Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sexual Dysfunction Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sexual Dysfunction Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sexual Dysfunction Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sexual Dysfunction Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Sexual Dysfunction Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sexual Dysfunction Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sexual Dysfunction Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sexual Dysfunction Drugs Tier 1, Tier 2, and Tier 3
4 Sexual Dysfunction Drugs Market by Type
  1. 4.1 Sexual Dysfunction Drugs Type Introduction
  2. 4.1.1 Hormonal Therapy
  3. 4.1.2 Transurethral Therapy
  4. 4.1.3 Oral Therapy
  5. 4.1.4 Intracavernosal Therapy
  6. 4.2 Global Sexual Dysfunction Drugs Sales by Type
  7. 4.2.1 Global Sexual Dysfunction Drugs Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Sexual Dysfunction Drugs Sales by Type (2021-2032)
  9. 4.2.3 Global Sexual Dysfunction Drugs Sales Market Share by Type (2021-2032)
  10. 4.3 Global Sexual Dysfunction Drugs Revenue by Type
  11. 4.3.1 Global Sexual Dysfunction Drugs Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Sexual Dysfunction Drugs Revenue by Type (2021-2032)
  13. 4.3.3 Global Sexual Dysfunction Drugs Revenue Market Share by Type (2021-2032)
5 Sexual Dysfunction Drugs Market by Application
  1. 5.1 Sexual Dysfunction Drugs Application Introduction
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Sexual Dysfunction Drugs Sales by Application
  5. 5.2.1 Global Sexual Dysfunction Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sexual Dysfunction Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Sexual Dysfunction Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Sexual Dysfunction Drugs Revenue by Application
  9. 5.3.1 Global Sexual Dysfunction Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sexual Dysfunction Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Sexual Dysfunction Drugs Revenue Market Share by Application (2021-2032)
6 Global Sexual Dysfunction Drugs Sales by Region
  1. 6.1 Global Sexual Dysfunction Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sexual Dysfunction Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Sexual Dysfunction Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Sexual Dysfunction Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sexual Dysfunction Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sexual Dysfunction Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sexual Dysfunction Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sexual Dysfunction Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sexual Dysfunction Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sexual Dysfunction Drugs Revenue by Region
  1. 7.1 Global Sexual Dysfunction Drugs Revenue by Region
  2. 7.1.1 Global Sexual Dysfunction Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sexual Dysfunction Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Sexual Dysfunction Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Sexual Dysfunction Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sexual Dysfunction Drugs Revenue (2021-2032)
  8. 7.2.2 North America Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sexual Dysfunction Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sexual Dysfunction Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sexual Dysfunction Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sexual Dysfunction Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Sexual Dysfunction Drugs Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Teva Pharmaceutical Industries
  8. 8.2.1 Teva Pharmaceutical Industries Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Sexual Dysfunction Drugs Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Sexual Dysfunction Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Eli Lilly
  20. 8.4.1 Eli Lilly Company Information
  21. 8.4.2 Eli Lilly Business Overview
  22. 8.4.3 Eli Lilly Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly Sexual Dysfunction Drugs Product Portfolio
  24. 8.4.5 Eli Lilly Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Sexual Dysfunction Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Sexual Dysfunction Drugs Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Sexual Dysfunction Drugs Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 AbbVie
  44. 8.8.1 AbbVie Company Information
  45. 8.8.2 AbbVie Business Overview
  46. 8.8.3 AbbVie Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AbbVie Sexual Dysfunction Drugs Product Portfolio
  48. 8.8.5 AbbVie Recent Developments
  49. 8.9 Vietstar Biomedical Research
  50. 8.9.1 Vietstar Biomedical Research Company Information
  51. 8.9.2 Vietstar Biomedical Research Business Overview
  52. 8.9.3 Vietstar Biomedical Research Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vietstar Biomedical Research Sexual Dysfunction Drugs Product Portfolio
  54. 8.9.5 Vietstar Biomedical Research Recent Developments
  55. 8.10 S1 Biopharma
  56. 8.10.1 S1 Biopharma Company Information
  57. 8.10.2 S1 Biopharma Business Overview
  58. 8.10.3 S1 Biopharma Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 S1 Biopharma Sexual Dysfunction Drugs Product Portfolio
  60. 8.10.5 S1 Biopharma Recent Developments
  61. 8.11 NexMed
  62. 8.11.1 NexMed Company Information
  63. 8.11.2 NexMed Business Overview
  64. 8.11.3 NexMed Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 NexMed Sexual Dysfunction Drugs Product Portfolio
  66. 8.11.5 NexMed Recent Developments
  67. 8.12 Leadiant Biosciences
  68. 8.12.1 Leadiant Biosciences Company Information
  69. 8.12.2 Leadiant Biosciences Business Overview
  70. 8.12.3 Leadiant Biosciences Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Leadiant Biosciences Sexual Dysfunction Drugs Product Portfolio
  72. 8.12.5 Leadiant Biosciences Recent Developments
  73. 8.13 Ivix LLX
  74. 8.13.1 Ivix LLX Company Information
  75. 8.13.2 Ivix LLX Business Overview
  76. 8.13.3 Ivix LLX Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Ivix LLX Sexual Dysfunction Drugs Product Portfolio
  78. 8.13.5 Ivix LLX Recent Developments
  79. 8.14 Emotional Brain
  80. 8.14.1 Emotional Brain Company Information
  81. 8.14.2 Emotional Brain Business Overview
  82. 8.14.3 Emotional Brain Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Emotional Brain Sexual Dysfunction Drugs Product Portfolio
  84. 8.14.5 Emotional Brain Recent Developments
  85. 8.15 Apricus Biosciences
  86. 8.15.1 Apricus Biosciences Company Information
  87. 8.15.2 Apricus Biosciences Business Overview
  88. 8.15.3 Apricus Biosciences Sexual Dysfunction Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Apricus Biosciences Sexual Dysfunction Drugs Product Portfolio
  90. 8.15.5 Apricus Biosciences Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sexual Dysfunction Drugs Value Chain Analysis
  2. 9.1.1 Sexual Dysfunction Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sexual Dysfunction Drugs Production Mode & Process
  6. 9.2 Sexual Dysfunction Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sexual Dysfunction Drugs Distributors
  9. 9.2.3 Sexual Dysfunction Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst